Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of the West of Scotland Coronary Prevention Study bio-bank to provide new insights into the control of plasma lipoprotein(a) concentrations.

Biochemical Society transactions - 1 Aug 1999

Gaw A, Brown E A, Docherty G, Ford I

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Immunoblotting
Share to Lipoprotein(a)
Share to Models, Statistical

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Share to Protein Isoforms

Share to Scotland

Source

Identifiers

PMID: 10917620
DOI: 10.1042/bst0270459

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of the West of Scotland Coronary Prevention Study bio-bank to provide new insights into the control of plasma lipoprotein(a) concentrations.PMID 10917620Read ↗

Role of Lipoprotein(a) Reduction in Cardiovascular DiseaseSemantic proximity Read ↗

Lipoprotein (a): When to Measure and How to Treat?Semantic proximity Read ↗

The role of Lipoprotein(a) and oxidized phospholipids in modifying the effects of aspirin on major cardiovascular events and bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) randomized clinical trial: Statistical analysis planSemantic proximity Read ↗

Lipoprotein(a), platelet function and cardiovascular disease.Semantic proximity Read ↗

Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart diseaseSemantic proximity Read ↗

New lipoprotein profiles and coronary heart disease. Improving precision of risk.Semantic proximity Read ↗

Studies in cardiovascular epidemiology in ScotlandSemantic proximity Read ↗

Value of Measuring Lipoprotein(a) During Cascade Testing for Familial HypercholesterolemiaSemantic proximity Read ↗

[Lipoprotein (a): variability and association with coronary disease].Semantic proximity Read ↗

Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort.Semantic proximity Read ↗

Therapeutic lowering of lipoprotein(a): How much is enough?Semantic proximity Read ↗

Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.